Models of Delivery of Care for AYA

  • Dan StarkEmail author
  • Andrea Ferrari


To design services for AYA with cancer, it is a given that we need to understand the patterns of disease. However more importantly we need to respond to the specific clinical and organisational challenges inherent in this patient group.


Delivery of care Cancer Adolescent Teenager Young adult 


  1. 1.
    Dommett RM, et al. Features of cancer in teenagers and young adults in primary care: a population-based nested case-control study. Br J Cancer. 2013;108(11):2329–33.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Ferrari A, et al. The sooner the better? How symptom interval correlates with outcome in children and adolescents with solid tumors: regression tree analysis of the findings of a prospective study. Pediatr Blood Cancer. 2016;63(3):479–85.PubMedCrossRefGoogle Scholar
  3. 3.
    Tricoli JV, et al. Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 2016;122(7):1017–28.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Rugbjerg K, et al. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009. J Natl Cancer Inst. 2014;106(6):dju110.PubMedCrossRefGoogle Scholar
  5. 5.
    Rugbjerg K, Olsen JH. Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer. JAMA Oncol. 2016;2(2):193–200.PubMedCrossRefGoogle Scholar
  6. 6.
    Woodward E, et al. Late effects in survivors of teenage and young adult cancer: does age matter? Ann Oncol. 2011;22(12):2561–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Morgan S, et al. Sex, drugs, and rock ‘n’ roll: caring for adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4825–30.PubMedCrossRefGoogle Scholar
  8. 8.
    World Health Organisation. Adolescent development. 2015.
  9. 9.
    Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–80.PubMedCrossRefGoogle Scholar
  10. 10.
    Viner RM, et al. Life course epidemiology: recognising the importance of adolescence. J Epidemiol Community Health. 2015;69(8):719–20.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Whitaker KJ, et al. Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome. Proc Natl Acad Sci USA. 2016;113(32):9105–10.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Erikson EH. Identity: youth and crisis. New York: Norton; 1968.Google Scholar
  13. 13.
    Abrams AN, Hazen EP, Penson RT. Psychosocial issues in adolescents with cancer. Cancer Treat Rev. 2007;33(7):622–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106(7):1425–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Potosky AL, et al. Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst. 2014;106(11):dju300.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Leonard RC, et al. Strategy needed for adolescent patients with cancer. BMJ. 1995;311(7001):387.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Lewis IJ. Cancer in adolescence. Br Med Bull. 1996;52(4):887–97.PubMedCrossRefGoogle Scholar
  18. 18.
    Nass SJ, et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist. 2015;20(2):186–95.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Stark D, et al. Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. Eur J Cancer Care (Engl). 2016;25(3):419–27.CrossRefGoogle Scholar
  20. 20.
    Barr RD, et al. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future. JAMA Pediatr. 2016;170(5):495–501.PubMedCrossRefGoogle Scholar
  21. 21.
    Veal GJ, Hartford CM, Stewart CF. Clinical pharmacology in the adolescent oncology patient. J Clin Oncol. 2010;28(32):4790–9.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Gramatges MM, Rabin KR. The adolescent and young adult with cancer: state of the art—acute leukemias. Curr Oncol Rep. 2013;15(4):317–24.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Vriens MR, et al. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011;117(2):259–67.PubMedCrossRefGoogle Scholar
  24. 24.
    Casanova M, et al. A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project. Cancer. 2012;118(10):2718–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Daniotti M, et al. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. J Invest Dermatol. 2009;129(7):1759–68.PubMedCrossRefGoogle Scholar
  26. 26.
    Chan JK, et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006;95(10):1314–20.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Tricoli JV, et al. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. 2011;103(8):628–35.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Collinson K, et al. Age-related biological features of germ cell tumors. Genes Chromosomes Cancer. 2014;53(3):215–27.PubMedCrossRefGoogle Scholar
  29. 29.
    Kohsaka S, et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet. 2014;46(6):595–600.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Kent EE, et al. Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer. J Adolesc Young Adult Oncol. 2013;2(2):44–52.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Hollis R, Morgan S. The adolescent with cancer—at the edge of no-man’s land. Lancet Oncol. 2001;2(1):43–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Kelly D, Pearce S, Mulhall A. ‘Being in the same boat’: ethnographic insights into an adolescent cancer unit. Int J Nurs Stud. 2004;41(8):847–57.PubMedCrossRefGoogle Scholar
  33. 33.
    Stark D, Lewis I. Improving outcomes for teenagers and young adults (TYA) with cancer. Klin Padiatr. 2013;225(6):331–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Clic-Sargent. A long way from home - the impact of travel on children and young people with cancer. London; 2010. p. 24.Google Scholar
  35. 35.
    Carr R, et al. Young adult cancer services in the UK: the journey to a national network. Clin Med. 2013;13(3):258–62.CrossRefGoogle Scholar
  36. 36.
    NICE(UK). Improving outcomes in children and young people with cancer. Cancer service guidance: London; 2005.Google Scholar
  37. 37.
    Taylor RM, et al. Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer. Health Qual Life Outcomes. 2015;13(1):107.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Whelan J, Barber J, Feltbower R, Fern L, Gibson F, Hooker L, Lerner M, Millington H, Moran A, Morris S, O’Hara C, Pearce S, Raine R, Stark D, Taylor R. Do specialised services for TYA with cancer add value? London: NIHR (UK); 2012.Google Scholar
  39. 39.
    Wolfson J, et al. Impact of treatment site in adolescents and young adults with central nervous system tumors. J Natl Cancer Inst. 2014;106(8):dju166.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
  41. 41.
    Jones LJ, Pini SA, Morgan SJ, Birk GK, Stark DP. How Do Teenagers and Young Adults with Cancer Experience Their Care? A European Survey. J Adolesc Young Adult Oncol. 2017;6(1):102–10. Epub 2016 Jun 17. PMID:27314907.
  42. 42.
    Bleyer WA, et al. American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #1: long-term care and lifetime follow-up. Cancer. 1993;71(7):2413.PubMedCrossRefGoogle Scholar
  43. 43.
    Statistics, O.f.N. Large increase in 20 to 34-year-olds living with parents since 1996. 2014.
  44. 44.
    Iacovou M. Leaving home: independence, togetherness and income in Europe. New York: United Nations, Department of Economic and Social Affairs; 2011.Google Scholar
  45. 45.
    Michelagnoli MP, Pritchard J, Phillips MB. Adolescent oncology—a homeland for the “lost tribe”. Eur J Cancer. 2003;39(18):2571–2.PubMedCrossRefGoogle Scholar
  46. 46.
    Stark D, et al. Survival patterns in teenagers and young adults with cancer in the United Kingdom: comparisons with younger and older age groups. Eur J Cancer. 2015;51(17):2643–54.PubMedCrossRefGoogle Scholar
  47. 47.
    Smith S. Adolescent units-an evidence-based approach to quality nursing in adolescent care. Eur J Oncol Nurs. 2004;8(1):20–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Marris S, Morgan S, Stark D. ‘Listening to Patients’: what is the value of age-appropriate care to teenagers and young adults with cancer? Eur J Cancer Care (Engl). 2011;20(2):145–51.CrossRefGoogle Scholar
  49. 49.
    Olsen PR, Harder I. Caring for teenagers and young adults with cancer: a grounded theory study of network-focused nursing. Eur J Oncol Nurs. 2011;15(2):152–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Perales MA, et al. Social media and the adolescent and young adult (AYA) patient with cancer. Curr Hematol Malig Rep. 2016;11(6):449–55.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Albritton K, Bleyer WA. The management of cancer in the older adolescent. Eur J Cancer. 2003;39(18):2584–99.PubMedCrossRefGoogle Scholar
  52. 52.
    Ferrari A, et al. Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol. 2010;28(32):4850–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Bleyer A. The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer. 2010;54(2):238–41.PubMedGoogle Scholar
  54. 54.
    Whiteson M. The Teenage Cancer Trust—advocating a model for teenage cancer services. Eur J Cancer. 2003;39(18):2688–93.PubMedCrossRefGoogle Scholar
  55. 55.
    Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G; RARECAREnet Working Group. Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols. Pediatr Blood Cancer. 2017;64(6). Epub 2016 Nov 24.
  56. 56.
    Goyal S, et al. Symptom interval in young people with bone cancer. Eur J Cancer. 2004;40(15):2280–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Martin S, et al. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12(7):816–24.PubMedCrossRefGoogle Scholar
  58. 58.
    Desandes E, et al. Pathways of care for adolescent patients with cancer in France from 2006 to 2007. Pediatr Blood Cancer. 2012;58(6):924–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Veneroni L, et al. Symptom interval in pediatric patients with solid tumors: adolescents are at greater risk of late diagnosis. Pediatr Blood Cancer. 2013;60(4):605–10.PubMedCrossRefGoogle Scholar
  60. 60.
    Fern LA, et al. Why can't we improve the timeliness of cancer diagnosis in children, teenagers, and young adults? BMJ. 2013;347:f6493.PubMedCrossRefGoogle Scholar
  61. 61.
    Lyratzopoulos G, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353–65.PubMedCrossRefGoogle Scholar
  62. 62.
    Ahrensberg JM, Fenger-Gron M, Vedsted P. Primary care use before cancer diagnosis in adolescents and young adults—a Nationwide Register Study. PLoS One. 2016;11(5):e0155933.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Forbes LJ, et al. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer. 2013;108(2):292–300.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Magni C, et al. Adolescents’ health awareness and understanding of cancer and tumor prevention: when and why an adolescent decides to consult a physician. Pediatr Blood Cancer. 2016;63(8):1357–61. Scholar
  65. 65.
    Magni C, et al. “There’s no reason why”: a campaign to raise cancer awareness among adolescents. Tumori. 2016;2016(3):270–5. Scholar
  66. 66.
    Rose PW, et al. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open. 2015;5(5):e007212.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Jensen H, et al. Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15:308.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Ingeman ML, et al. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15:421.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Larsen MB, et al. Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative before-after study. BMC Health Serv Res. 2013;13:348.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Committee LFR. Livestrong young adult alliance implementation plan. Austin: Livestrong; 2014.Google Scholar
  71. 71.
    Livestrong. Closing the gap: a strategic plan. Austin: Livestrong; 2007.Google Scholar
  72. 72.
    Fern LA, Stark DP, Phillips B, Morgan S, Azzim A, Gibson F. Benchmarking teenage and young adult cancer professional developments across Europe: A Delphi Survey. In European cancer congress. Amsterdam; 2013.Google Scholar
  73. 73.
    Smith S. In: Case L, editor. A blueprint of care for teenagers and young adults with cancer. London, UK: Teenage Cancer Trust; 2013.Google Scholar
  74. 74.
    GMC (UK). Curriculum for specialty training in medical oncology. 2010.
  75. 75.
    Hayes-Lattin B, Mathews-Bradshaw B, Siegel S. Adolescent and young adult oncology training for health professionals: a position statement. J Clin Oncol. 2010;28(32):4858–61.PubMedCrossRefGoogle Scholar
  76. 76.
    Ercan O, et al. Demography of adolescent health care delivery and training in Europe. Eur J Pediatr. 2009;168(4):417–26.PubMedCrossRefGoogle Scholar
  77. 77.
    Ramphal R, et al. Practices and resources devoted to the care of adolescents and young adults with cancer in canada: a survey of pediatric and adult cancer treatment centers. J Adolesc Young Adult Oncol. 2011;1(3):140–4.PubMedCrossRefGoogle Scholar
  78. 78.
    Bernig T, et al. Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting: on the way to a highly specialized AYA unit. Klin Padiatr. 2013;225(6):335–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Ferrari A, et al. Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. Eur J Cancer. 2009;45(3):328–34.PubMedCrossRefGoogle Scholar
  80. 80.
    Ferrari A. The challenge of access to care for adolescents with cancer In Italy: national and local pediatric oncology programs. J Adolesc Young Adult Oncol. 2013;2(3):112–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Ferrari A. SIAMO: Italian pediatric oncologists and adult medical oncologists join forces for adolescents with cancer. Pediatr Hematol Oncol. 2014;31(6):574–5.PubMedCrossRefGoogle Scholar
  82. 82.
    Ferrari A, et al. Adolescents with cancer in Italy: improving access to national cooperative pediatric oncology group (AIEOP) centers. Pediatr Blood Cancer. 2016;63(6):1116–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Aben KK, et al. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009. Acta Oncol. 2012;51(7):922–33.PubMedCrossRefGoogle Scholar
  84. 84.
    Lassaletta A, Andión M, Garrido-Colino C. The current situation of adolescents with cancer in pediatric hematology-oncology units in Spain. Results of a national survey. An Pediatr (Barc). 2013;78(4):268.e1–7.CrossRefGoogle Scholar
  85. 85.
    Bleyer A. The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care. 2005;35(5):182–217.PubMedCrossRefGoogle Scholar
  86. 86.
    Bleyer A, O’Leary M, Barr R, LAG R. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival, 1975–2000. Bethesda: National Cancer Institute; 2006.Google Scholar
  87. 87.
    Johnson RH. AYA in the USA. International perspectives on AYAO, part 5. J Adolesc Young Adult Oncol. 2013;2(4):167–74.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Smith AW, et al. Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol. 2013;31(17):2136–45.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Mathews-Bradshaw B, et al. The history and accomplishments of the livestrong young adult alliance. J Adolesc Young Adult Oncol. 2011;1(1):43–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Zebrack B, Mathews-Bradshaw B, Siegel S. Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol. 2010;28(32):4862–7.PubMedCrossRefGoogle Scholar
  91. 91.
    Reed D, Block RG, Johnson R. Creating an adolescent and young adult cancer program: lessons learned from pediatric and adult oncology practice bases. J Natl Compr Canc Netw. 2014;12(10):1409–15.PubMedCrossRefGoogle Scholar
  92. 92.
  93. 93.
    Keegan TH, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–16.PubMedCrossRefGoogle Scholar
  94. 94.
    Parsons HM, et al. Who treats adolescents and young adults with cancer? A report from the AYA HOPE Study. J Adolesc Young Adult Oncol. 2015;4(3):141–50.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Smith, A.W., et al., Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future. Cancer, 2016.Google Scholar
  96. 96.
    Parsons HM, et al. Young and uninsured: Insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352–60.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Parsons HM, et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011;29(30):4045–53.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Roth ME, et al. Low enrollment of adolescents and young adults onto cancer trials: insights from the community clinical oncology program. J Oncol Pract. 2016;12(4):e388–95.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Shaw PH, et al. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions. Cancer. 2012;118(14):3614–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Weiss AR, Nichols CR, Freyer DR. Enhancing adolescent and young adult oncology research within the national clinical trials network: rationale, progress, and emerging strategies. Semin Oncol. 2015;42(5):740–7.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Freyer DR, Felgenhauer J, Perentesis J. Children’s Oncology Group’s 2013 blueprint for research: adolescent and young adult oncology. Pediatr Blood Cancer. 2013;60(6):1055–8.PubMedCrossRefGoogle Scholar
  102. 102.
    Olson TA, et al. Pediatric and adolescent extracranial germ cell tumors: the road to collaboration. J Clin Oncol. 2015;33(27):3018–28.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Fernandez C, et al. Principles and recommendations for the provision of healthcare in canada to adolescent and young adult-aged cancer patients and survivors. J Adolesc Young Adult Oncol. 2011;1(1):53–9.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Rogers PC, et al. A process for change in the care of adolescents and young adults with cancer in canada. “Moving to action”: the Second Canadian International Workshop. International perspectives on AYAO, part 1. J Adolesc Young Adult Oncol. 2013;2(2):72–6.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Ramphal R, et al. Active therapy and models of care for adolescents and young adults with cancer. Cancer. 2011;117(10 Suppl):2316–22.PubMedCrossRefGoogle Scholar
  106. 106.
    Baxter NN, et al. The initiative to maximize progress in adolescent and young adult cancer therapy (IMPACT) cohort study: a population-based cohort of young Canadians with cancer. BMC Cancer. 2014;14:805.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    White V, et al. The Australian-Canadian adolescent and young adult collaborative cohort initiative: initial meeting report. J Adolesc Young Adult Oncol. 2016;6(1):1–5.PubMedCrossRefGoogle Scholar
  108. 108.
    Gupta AA, et al. Reimagining care for adolescent and young adult cancer programs: moving with the times. Cancer. 2016;122(7):1038–46.PubMedCrossRefGoogle Scholar
  109. 109.
    Xu Y, et al. Quantifying treatment delays in adolescents and young adults with cancer at McGill University. Curr Oncol. 2015;22(6):e470–7.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Palmer S, Patterson P, Thompson K. A national approach to improving adolescent and young adult (AYA) oncology psychosocial care: the development of AYA-specific psychosocial assessment and care tools. Palliat Support Care. 2014;12(3):183–8.PubMedCrossRefGoogle Scholar
  111. 111.
    Magrath I, Epelman S. Cancer in adolescents and young adults in countries with limited resources. Curr Oncol Rep. 2013;15(4):332–46.PubMedCrossRefGoogle Scholar
  112. 112.
  113. 113.
    SIOP-E. SIOP-E Strategic plan 2015-2020. 2015.

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.St James HospitalLeedsUK
  2. 2.Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale TumoriMilanoItaly

Personalised recommendations